Evidence-based interventions in the early phase of schizophrenic disordersAbstract. By addressing the early phase of first episode psychosis, we focus on the “critical period” in the development of schizophrenia. Treatment success during this vulnerable ...
The debate about personal genomics and their role in personalized medicine has been, to some extent, hijacked by the controversy about commercially available genomic tests sold directly to consumers. The clinical validity and utility of such tests are ...
Personalized medicine has a substantial potential to transform the way diseases will be predicted, prevented and treated. The field will greatly benefit from novel DNA sequencing technologies, in particular commoditization of individual whole genome ...